Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Sanit Technologies, LLC dba Durisan
WARNING LETTER
•Sanit Technologies, LLC dba Durisan•March 5, 2021

Sanit Technologies, LLC dba Durisan – FDA Warning Letter, Mar 5, 2021

Record Details

The FDA inspected Sanit Technologies LLC., dba Durisan, a drug manufacturing facility, from March 1 to 5, 2021, and found significant violations of current good manufacturing practice (CGMP) regulations (21 CFR parts 210 and 211). Consequently, the firm's drug products are deemed adulterated under section 501(a)(2)(B) of the FD&C Act. Key deficiencies included the quality control unit's failure to ensure drug products met CGMP and established specifications, leading to the release of Durisan Hand Sanitizer, Alcohol-Free, that failed microbial count specifications. Specifically, products were released with high levels of bacteria and yeast/molds, including Burkholderia cepacia, an opportunistic pathogen. The quality unit also failed to uphold commitments made during a prior regulatory meeting regarding water system monitoring, knowingly releasing contaminated water for manufacturing. Furthermore, there was a lack of adequate procedures and oversight for finished product specifications and the stability program. The firm acknowledged ceasing all drug product manufacturing and distribution from the site as of June 30, 2021. Remediation of these CGMP violations is required if operations resume. The FDA demands a written response within 15 working days detailing corrective actions and prevention measures, warning of potential legal action, contract withholding, and export certificate denial if violations remain unaddressed.

Company
Sanit Technologies, LLC dba Durisan
Inspection date
March 5, 2021
Product type
Drugs
Office
Office of Pharmaceutical Quality Operations Division I
People
  • John W. Diehl (John W. Diehl, M.S.Program Division)
  • Osman Lambiro
  • Guy Gabriel
View Company Profile

ID · 99db819a-4031-4e71-8561-ef607a06e726

Violation Codes5
21 U.S.C. 351(a)(2)(B)21 CFR 21021 CFR 21121 CFR 211.22FD&C Act 501(a)(2)(B)

Full citation text and observation details available on the Dashboard.

Other documents for Sanit Technologies, LLC dba Durisan
  • 483 - 2021-03-05March 5, 2021
  • WARNING_LETTER - 2020-04-15April 15, 2020
  • 483 - 2019-05-17May 17, 2019

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Sanit Technologies, LLC dba Durisan
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.